Page last updated: 2024-08-23

prenalterol and Cardiomyopathies

prenalterol has been researched along with Cardiomyopathies in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braun, G; Effert, S; Erbel, R; Krebs, W; Lambertz, H; Meyer, J; Schweizer, P; Voelker, W1
Pflederer, W1
Effert, S; Erbel, R; Lambertz, H; Meyer, J; Schweizer, P; Voelker, W1
Bartorelli, A; Fiorentini, C; Guazzi, MD; Loaldi, A; Moruzzi, P; Olivari, MT; Polese, A; Qing, LG1
Doering, W; Isbary, J; Wauer, B1
Balazs, T; Joseph, X1

Other Studies

6 other study(ies) available for prenalterol and Cardiomyopathies

ArticleYear
Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
    Circulation, 1982, Volume: 66, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Blood Volume; Cardiomyopathies; Coronary Disease; Female; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Practolol; Prenalterol

1982
[Therapy of cardiomyopathies].
    Fortschritte der Medizin, 1982, Aug-26, Volume: 100, Issue:31-32

    Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Anticoagulants; Captopril; Cardiac Glycosides; Cardiomyopathies; Diet, Sodium-Restricted; Digitoxin; Digoxin; Dihydralazine; Diuretics; Humans; Nitrates; Practolol; Prenalterol; Temperance; Vasodilator Agents; Verapamil

1982
Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Acta medica Scandinavica. Supplementum, 1982, Volume: 659

    Topics: Adrenergic beta-Agonists; Blood Pressure; Cardiac Catheterization; Cardiomyopathies; Coronary Disease; Drug Evaluation; Heart; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Practolol; Prenalterol; Radiography; Stroke Volume; Vascular Resistance

1982
Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Acta medica Scandinavica. Supplementum, 1982, Volume: 659

    Topics: Adrenergic beta-Agonists; Adult; Blood Circulation; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Middle Aged; Monitoring, Physiologic; Practolol; Prenalterol; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance

1982
Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
    Acta medica Scandinavica. Supplementum, 1982, Volume: 659

    Topics: Adrenergic beta-Agonists; Cardiac Catheterization; Cardiac Output; Cardiomyopathies; Female; Heart; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Practolol; Prenalterol; Pulmonary Heart Disease; Rest; Stroke Volume

1982
Enhanced myocardial necrosis induced in rats by the combined administration of hydralazine and prenalterol.
    The Journal of pharmacy and pharmacology, 1986, Volume: 38, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Drug Interactions; Hydralazine; Male; Myocardium; Necrosis; Prenalterol; Rats; Rats, Inbred Strains

1986